|
| Entrez Id: |
7157 |
| Gene Symbol: |
TP53 |
TP53
|
0.500 |
Biomarker
|
disease |
CTD_mouse |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
7157 |
| Gene Symbol: |
TP53 |
TP53
|
0.500 |
Biomarker
|
disease |
CTD_human |
Localization of chloroacetaldehyde-induced DNA damage in human p53 gene by DNA polymerase fingerprint analysis.
|
10626228 |
1999 |
|
| Entrez Id: |
8517 |
| Gene Symbol: |
IKBKG |
IKBKG
|
0.300 |
Biomarker
|
disease |
CTD_human |
Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease.
|
30737368 |
2019 |
|
| Entrez Id: |
355 |
| Gene Symbol: |
FAS |
FAS
|
0.300 |
Biomarker
|
disease |
CTD_human |
Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease.
|
30737368 |
2019 |
|
| Entrez Id: |
6364 |
| Gene Symbol: |
CCL20 |
CCL20
|
0.300 |
Biomarker
|
disease |
CTD_human |
Pancreatic carcinoma cells colonizing the liver modulate the expression of their extracellular matrix genes.
|
30603057 |
2018 |
|
| Entrez Id: |
4313 |
| Gene Symbol: |
MMP2 |
MMP2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Pancreatic carcinoma cells colonizing the liver modulate the expression of their extracellular matrix genes.
|
30603057 |
2018 |
|
| Entrez Id: |
27113 |
| Gene Symbol: |
BBC3 |
BBC3
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
595 |
| Gene Symbol: |
CCND1 |
CCND1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
596 |
| Gene Symbol: |
BCL2 |
BCL2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
7040 |
| Gene Symbol: |
TGFB1 |
TGFB1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
5595 |
| Gene Symbol: |
MAPK3 |
MAPK3
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
5594 |
| Gene Symbol: |
MAPK1 |
MAPK1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
6774 |
| Gene Symbol: |
STAT3 |
STAT3
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
7124 |
| Gene Symbol: |
TNF |
TNF
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
578 |
| Gene Symbol: |
BAK1 |
BAK1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
598 |
| Gene Symbol: |
BCL2L1 |
BCL2L1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
3717 |
| Gene Symbol: |
JAK2 |
JAK2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
|
28100771 |
2017 |
|
| Entrez Id: |
3265 |
| Gene Symbol: |
HRAS |
HRAS
|
0.300 |
Biomarker
|
disease |
CTD_human |
Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
|
27517622 |
2016 |
|
| Entrez Id: |
5052 |
| Gene Symbol: |
PRDX1 |
PRDX1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
|
27517622 |
2016 |
|
| Entrez Id: |
3569 |
| Gene Symbol: |
IL6 |
IL6
|
0.300 |
Biomarker
|
disease |
CTD_human |
Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis.
|
26297436 |
2015 |
|
| Entrez Id: |
9970 |
| Gene Symbol: |
NR1I3 |
NR1I3
|
0.300 |
Biomarker
|
disease |
CTD_human |
Involvement of constitutive androstane receptor in liver hypertrophy and liver tumor development induced by triazole fungicides.
|
25656644 |
2015 |
|
| Entrez Id: |
6774 |
| Gene Symbol: |
STAT3 |
STAT3
|
0.300 |
Biomarker
|
disease |
CTD_human |
Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis.
|
26297436 |
2015 |
|
| Entrez Id: |
999 |
| Gene Symbol: |
CDH1 |
CDH1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Chemically induced mouse liver tumors are resistant to treatment with atorvastatin.
|
25319454 |
2014 |
|
| Entrez Id: |
9970 |
| Gene Symbol: |
NR1I3 |
NR1I3
|
0.300 |
Biomarker
|
disease |
CTD_human |
CAR-mediated repression of Foxo1 transcriptional activity regulates the cell cycle inhibitor p21 in mouse livers.
|
24769335 |
2014 |
|
| Entrez Id: |
1356 |
| Gene Symbol: |
CP |
CP
|
0.300 |
Biomarker
|
disease |
CTD_human |
Non-hepatic tumors change the activity of genes encoding copper trafficking proteins in the liver.
|
23792645 |
2013 |